Coughlin Timothy bought VIR
June 9, 2026 · Form 4 insider transaction
Coughlin Timothy bought 16,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,000
Price
$0.00
Total value
N/A
InsiderCoughlin Timothy
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 10, 2026
Shares owned after16,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.